BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Fish and Richardson
Baxter
Moodys
Federal Trade Commission
Julphar
Accenture
Boehringer Ingelheim
Medtronic

Generated: January 23, 2018

DrugPatentWatch Database Preview

Terazosin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for terazosin hydrochloride and what is the scope of terazosin hydrochloride patent protection?

Terazosin hydrochloride
is the generic ingredient in two branded drugs marketed by Abbott, Apotex, Ivax Sub Teva Pharms, Jubilant Cadista, Mylan Pharms Inc, Mylan Technologies, Ranbaxy Labs Ltd, Sandoz, and Teva, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for terazosin hydrochloride. Twenty-eight suppliers are listed for this compound.
Pharmacology for terazosin hydrochloride

US Patents and Regulatory Information for terazosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 075667-002 Jul 28, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz TERAZOSIN HYDROCHLORIDE terazosin hydrochloride TABLET;ORAL 074315-001 Dec 31, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz TERAZOSIN HYDROCHLORIDE terazosin hydrochloride TABLET;ORAL 074315-004 Dec 31, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms TERAZOSIN HYDROCHLORIDE terazosin hydrochloride TABLET;ORAL 074530-004 Apr 21, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Technologies TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 075384-002 Dec 1, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-004 Dec 14, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 074823-003 Mar 30, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ranbaxy Labs Ltd TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 076021-003 Aug 22, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-002 Dec 14, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 075498-002 Apr 12, 2001 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for terazosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-004 Aug 7, 1987 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-001 Aug 7, 1987 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-003 Dec 14, 1994 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-004 Dec 14, 1994 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-002 Dec 14, 1994 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-001 Dec 14, 1994 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-004 Aug 7, 1987 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-001 Aug 7, 1987 ➤ Subscribe ➤ Subscribe
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-002 Aug 7, 1987 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Dow
UBS
Harvard Business School
Merck
Covington
Fuji
Baxter
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot